Furthermore, in vivo transplantation mouse models using primary human MLL-AF4 and -ENL leukaemias have demonstrated that committed progenitors with a CD34+CD38+CD19+ surface marker phenotype were able to give rise to infant ALL [54]. Here, KMT2A is linked to leukemia.